Profile data is unavailable for this security.
About the company
Beijing Tong Ren Tang Chinese Medicine Co Ltd is an investment holding company principally engaged in the manufacturing and sale of Chinese medicine. The Company operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. It is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
- Revenue in HKD (TTM)1.71bn
- Net income in HKD515.36m
- Incorporated2004
- Employees789.00
- LocationBeijing Tong Ren Tang Chinese Medicine Co LtdRoom 1405-1409, Office Tower, Hong KongHKG
- Phone+852 36575819
- Fax+852 28817606
- Websitehttps://cm.tongrentang.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIM Vaccine Co Ltd | 1.43bn | -304.43m | 3.90bn | 1.49k | -- | 1.04 | -- | 2.73 | -0.2504 | -0.2504 | 1.17 | 3.05 | 0.174 | 0.7724 | 1.12 | 930,483.40 | -3.71 | -8.04 | -6.66 | -12.31 | 71.80 | 79.64 | -21.32 | -39.38 | 0.5882 | -3.70 | 0.3341 | -- | 8.22 | 6.19 | 78.69 | -- | -7.20 | -- |
| Shandong Boan Biotechnology Co Ltd | 856.16m | 36.24m | 4.73bn | 714.00 | 119.56 | 1.90 | 35.89 | 5.52 | 0.0636 | 0.0636 | 1.51 | 4.00 | 0.2530 | 1.34 | 1.73 | 1,053,085.00 | 1.07 | -- | 1.41 | -- | 71.70 | -- | 4.23 | -- | 1.45 | 1.81 | 0.2827 | -- | 17.50 | -- | 161.31 | -- | -- | -- |
| VIVA Biotech Holdings | 2.08bn | 194.91m | 4.90bn | 2.09k | 32.48 | 1.10 | 9.75 | 2.36 | 0.0708 | 0.0708 | 0.6808 | 2.09 | 0.2612 | 4.24 | 4.94 | 1,007,213.00 | 3.22 | -1.28 | 3.81 | -1.56 | 37.44 | 34.30 | 12.33 | -4.94 | 1.44 | -- | 0.2283 | -- | -7.84 | 43.80 | 244.08 | -8.85 | 27.82 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -153.71m | 5.17bn | 197.00 | -- | 6.24 | -- | -- | -0.7658 | -0.7658 | 0.00 | 4.17 | 0.00 | -- | -- | 0.00 | -12.48 | -- | -13.69 | -- | -- | -- | -- | -- | 4.68 | -- | 0.2296 | -- | -- | -- | 32.53 | -- | -- | -- |
| Tong Ren Tang Technologies Co Ltd | 7.86bn | 488.40m | 5.66bn | 3.89k | 11.59 | 0.6858 | 4.58 | 0.7202 | 0.3813 | 0.3813 | 6.14 | 6.44 | 0.482 | 0.8615 | 6.00 | 1,969,535.00 | 5.47 | 7.44 | 8.57 | 12.07 | 39.82 | 42.21 | 11.34 | 15.10 | 2.79 | -- | 0.1913 | 39.34 | 7.18 | 10.15 | -11.59 | 4.55 | -8.30 | 3.37 |
| Ocumension Therapeutics | 615.11m | -281.98m | 5.71bn | 505.00 | -- | 1.38 | -- | 9.28 | -0.3764 | -0.3764 | 0.8214 | 5.08 | 0.1571 | 4.30 | 3.35 | 1,257,900.00 | -7.20 | -24.03 | -7.62 | -25.71 | 42.58 | 58.38 | -45.84 | -400.90 | 4.86 | -- | 0.0223 | -- | 69.38 | 365.95 | 29.36 | -- | 213.01 | -- |
| Beijing Tong Ren Tang Chinese Medicine | 1.71bn | 515.36m | 7.53bn | 789.00 | 14.62 | 1.87 | 12.00 | 4.41 | 0.6157 | 0.6157 | 2.04 | 4.81 | 0.3878 | 0.4134 | 4.92 | 2,185,246.00 | 12.14 | 15.34 | 13.34 | 17.17 | 63.00 | 68.94 | 31.29 | 39.16 | 11.43 | -- | 0.0327 | 52.52 | 5.69 | 2.38 | -7.42 | -2.09 | 20.50 | 8.76 |
| China Shineway Pharmaceutical Group Ltd | 3.78bn | 936.99m | 8.10bn | 2.87k | 7.89 | 0.9164 | 10.39 | 2.14 | 1.24 | 1.24 | 5.01 | 10.68 | 0.3299 | 1.15 | 3.81 | 1,174,894.00 | 8.17 | 8.29 | 10.75 | 10.38 | 73.36 | 74.83 | 24.77 | 18.67 | 3.39 | -- | 0.0419 | 37.49 | -16.35 | 6.90 | -13.35 | 10.80 | 8.92 | 19.39 |
| CStone Pharmaceuticals | 229.08m | -426.61m | 8.72bn | 93.00 | -- | 22.63 | -- | 38.08 | -0.3273 | -0.3273 | 0.1768 | 0.2612 | 0.1487 | 1.38 | 1.68 | 1,696,892.00 | -27.69 | -39.13 | -54.45 | -60.19 | -12.18 | 66.69 | -186.23 | -170.86 | 1.20 | -29.83 | 0.554 | -- | -12.21 | -- | 75.16 | -- | -- | -- |
| SSY Group Ltd | 4.58bn | 658.92m | 8.76bn | 5.70k | 13.54 | 1.23 | 7.79 | 1.91 | 0.223 | 0.223 | 1.55 | 2.46 | 0.3616 | 2.27 | 2.11 | 751,065.60 | 5.27 | 9.41 | 6.34 | 12.43 | 42.68 | 56.47 | 14.58 | 17.65 | 2.40 | 14.91 | 0.346 | 42.91 | -10.67 | 4.49 | -19.53 | -1.36 | -8.36 | 9.73 |
| Hbm Holdings Ltd | 904.32m | 571.07m | 10.28bn | 210.00 | 15.96 | 4.25 | 17.19 | 11.37 | 0.7405 | 0.7405 | 1.14 | 2.78 | 0.3856 | 6.32 | 32.64 | 5,796,901.00 | 24.77 | -42.87 | 30.77 | -53.24 | 92.95 | 96.12 | 64.25 | -292.58 | 6.02 | 28.63 | 0.1857 | -- | -57.43 | 47.71 | -87.81 | -- | -55.31 | -- |
| China Traditional Chinese Med Hldg CoLtd | 17.63bn | -299.61m | 10.32bn | 15.58k | -- | 0.4408 | 11.36 | 0.5854 | -0.0595 | -0.0595 | 3.50 | 4.65 | 0.4326 | 1.59 | 1.71 | 1,052,615.00 | -0.93 | 3.48 | -1.42 | 5.24 | 47.66 | 54.69 | -2.15 | 7.39 | 1.51 | 9.55 | 0.1333 | 21.27 | -8.90 | 2.89 | -95.79 | -49.14 | -15.28 | -48.82 |
| Luye Pharma Group Ltd | 6.98bn | 449.06m | 10.79bn | 5.12k | 22.62 | 0.611 | 6.74 | 1.55 | 0.1194 | 0.1194 | 1.86 | 4.42 | 0.2083 | 2.42 | 2.37 | 1,354,931.00 | 1.91 | 1.98 | 3.26 | 3.16 | 66.85 | 68.37 | 9.15 | 8.04 | 1.24 | 2.35 | 0.4227 | 0.00 | -1.33 | -0.9503 | -11.40 | -19.50 | -10.95 | -- |
| Fujian Haixi Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.92bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 47.39 | -- | 15.86 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to Beijing Tong Ren Tang Chinese Medicine Co Ltd's reporting currency: Hong Kong Dollar HKD
3.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 11.44m | 1.37% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 4.56m | 0.54% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 4.47m | 0.53% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 1.93m | 0.23% |
| Dodge & Coxas of 31 Dec 2025 | 1.45m | 0.17% |
| Value Partners Ltd.as of 30 Jun 2025 | 897.00k | 0.11% |
| Value Partners Hong Kong Ltd.as of 30 Jun 2025 | 841.00k | 0.10% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 755.34k | 0.09% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 702.00k | 0.08% |
| E Fund Asset Management Co. Ltd.as of 30 Jun 2025 | 541.00k | 0.07% |
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
